+1 (713) 400-6400
3200 Southwest Fwy #2240 Phoenix TowerHouston, TX 77027
© 2020 Marker Therapeutics, Inc.
Dr. Glynn Wilson, Chairman and CEO of TapImmune, will present at the 2017 Biotechnology Innovation Organization International Convention held on June 19-22 in San Diego.
TapImmune, Inc. (NASDAQ: TPIV), today announced its Chairman and CEO, Dr. Glynn Wilson, will present at Biotech Showcase 2017 to be held January 9-11, 2017, at the Hilton San Francisco Union Square.
Get Marker News Delivered To Your Inbox